Jefferies, BofA, Piper Sandler and Barclays acted as joint book running managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TSHA:
- Taysha Gene Therapies price target raised to $6 from $5 at Citizens JMP
- Taysha Gene Therapies Announces Pivotal Trial Design for TSHA-102
- Taysha Gene Therapies announces Part B trial design for TSHA-102
- Taysha Gene Therapies announces common stock offering, no amount given
- Positive Developments and Strategic Moves Position Taysha Gene Therapies for Success with TSHA-102
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue